Aim: The aim of the present study to evaluate the rheumatological manifestations amongst Patients with Type 2 Diabetes. Methods: This was a prospective study conducted in the Department of Biochemistry, PMCH, Bihar, India, Total 120 patients of already diagnosed type 2 diabetes mellitus were included in this study. The selected patients were subjected to further evaluation using Baseline diabetic questionnaire: Name, age, sex, occupation especially manual labor, height, weight, BMI (We considered overweight subjects with a BMI between25 and 29.9 and obesity with BMI >30 kg/m2), duration and onset of type 2 diabetes, smoking habits, any historyof systemic diseases, medications: oral hypoglycemic orinsulin injection, blood sugar level: fasting, post prandial and glycosylated hemoglobin. Musculoskeletal system was systematically examined. Results: Most of the patients were between 60-70 years of age and were 41.67% of the total patients. In our study out of 120 diabetic patients 35 had rheumatological manifestations.The most common manifestation was Osteoarthritis which was found to be present in 15.83% cases. Second most common complication was Adhesive capsulitis which was found to be present in 12.5% cases. The prevalence of Carpal tunnel syndrome was found to be 7.5% in diabetic individuals in present study. Flexor tenosynovitis was found to have a prevalence of 6.67%. Diabetic cheiroarthropathy was found in 5% of patients. Diabetic amyotrophy and Dupuytren’s contracture were found to have a prevalence of 1.67% each in patients suffering from T2DM. Out of 120 patients 35 had rheumatological manifestations out of which 15 were males and 20 were females. 40 males and 45 females were without rheumatological manifestations. Conclusion: The diabetic patients need to be regularly screened for rheumatological complications or any bone disorders. This could be helpful inpreventing chronic disability in patients and improving their quality of life. Good glycemic control is a key to prevent rheumatological manifestations in patients with T2DM.